• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.07% Nasdaq Up0.32%

    Emergent BioSolutions, Inc. (EBS)

    -NYSE
    34.64 Up 0.36(1.05%) Aug 28, 4:04PM EDT
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2014Dec 31, 2013Dec 31, 2012
    Total Revenue 450,138   312,745   281,888  
    Cost of Revenue118,412  62,127  46,077  
    Gross Profit 331,726   250,618   235,811  
    Operating Expenses
    Research Development150,829  119,933  120,226  
    Selling General and Administrative122,841  87,883  76,018  
    Non Recurring -   -  9,600  
    Others -   -   -  
    Total Operating Expenses -   -   -  
    Operating Income or Loss 58,056   42,802   29,967  
    Income from Continuing Operations
    Total Other Income/Expenses Net3,246  565  2,104  
    Earnings Before Interest And Taxes61,302  43,367  32,071  
    Interest Expense8,240   -  6  
    Income Before Tax53,062  43,367  32,065  
    Income Tax Expense16,321  13,108  13,922  
    Minority Interest -  876  5,381  
    Net Income From Continuing Ops36,741  31,135  23,524  
    Non-recurring Events
    Discontinued Operations -   -   -  
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income 36,741   31,135   23,524  
    Preferred Stock And Other Adjustments -   -   -  
    Net Income Applicable To Common Shares 36,741   31,135   23,524  

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.